학술논문
A prospective, randomized, phase II study to assess the schemas of retreatment with Lutathera® in patients with new progression of an intestinal, well-differentiated neuroendocrine tumor (ReLUTH)
Document Type
Article
Author
Source
In: BMC Cancer . (BMC Cancer, December 2022, 22(1))
Subject
Language
English
ISSN
14712407